Newsroom
Newsroom
Rotech Plans Seamless Leadership Transition
ORLANDO, Fla. – Effective January 1, 2024, Tim Pigg has transitioned from the Chief Executive Officer (CEO) to Executive Chairman of the Board. He has served in the CEO position for the past 10 years and various other leadership positions for a total of 40 years with Rotech.
In his new role, Pigg will continue to invest his time in the company’s major strategies and lobbying efforts.
Robin Menchen has advanced from the President and Chief Operating Officer (COO) to President and CEO for Rotech Healthcare Inc. (Rotech). Menchen has also served as the company’s Chief Administrative Officer (CAO), VP of Compliance and various other leadership roles over the past 30 years.
“I have worked closely with Robin for over 2 decades and she has consistently demonstrated exceptional leadership, vision, and a deep understanding of Rotech’s goals and values. I am confident Robin, with the continued support of the executive team, will continue to drive our company’s success,” Pigg said, “It has been an honor and a privilege to serve as Rotech’s CEO, and I will cherish the memories and relationships I have forged during my tenure.”
Rotech is one of the largest providers of home medical equipment and related products and services (collectively referred to as “HME products and services”) in the United States, with a comprehensive offering of oxygen, other respiratory therapy equipment, wound care equipment and supplies, and diabetes devices and supplies. The Company provides HME products and services in 50 states through approximately 300 operating locations.
Philips Respironics Device Recall
Philips Respironics announced a voluntary recall for certain CPAP, BiLevel PAP and Ventilator Devices manufactured prior to April 21, 2021. This recall is due to two issues related to the polyester-based polyurethane (PE-PUR) sound abatement foam used in these devices. Philips is notifying customers and users of affected devices that they will replace the current sound abatement foam with a new material that is not affected by this issue. Affected devices currently will be either replaced with a new or refurbished unit that incorporates the new material, or repaired to replace the sound abatement foam in customer units. For more information on the Recall Notice, a complete list of impacted products, and more information, visit philips.com/src-update . Rotech is committed to providing safe CPAP/BiPAP and Ventilator equipment for all…
Rotech Completes Refinancing
New 5-year $425 million Credit Facility ORLANDO, Fla.— On December 17, 2020, Rotech Healthcare Inc. (Rotech) entered into a new $425 million amended and restated credit agreement with a diversified group of lenders including Truist Bank, as Administrative Agent, Swingline Lender and Issuing Bank, Citizens Bank, Fifth Third Bank, National Association, and Regions Bank, as Co-Syndication Agents, Truist Securities, Inc., Citizens Bank, Fifth Third Bank, National Association, and Regions Bank, as Joint Lead Arrangers and Joint Bookrunners and Manufacturers and Traders Trust Company, as Documentation Agent (the “Credit Agreement”). The Credit Agreement is comprised of a $335 million five year term loan, a $15 million revolving credit facility and a $75 million acquisition credit facility. The proceeds of this transaction were used to pay a…
The Rotech App: Now Available!
Now your patient information is in your hands! Rotech’s new mobile app allows patients to access all of their Rotech account information right at their fingertips.